SEC Form 4 · accession 0001127602-19-001736
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Jan 8, 2019
Accepted (ET)
Jan 10, 2019 · 9:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 8, 2019 | S | 25,000 | $115.00 | D | 235,771 | D | |
| Common Stock | holding | — | — | — | 18,390 | I | 2017 GRAT | |
| Common StockF3 | holding | — | — | — | 25,000 | I | 2018 GRAT | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.
- F2On 09/24/2018, the reporting person contributed 25,000 shares of CRL Common Stock to a grantor retained annuity trust for the benefit of himself and his two adult children.
- F3On 09/24/2018, the reporting person contributed 25,000 shares of CRL Common Stock to a grantor retained annuity trust for the benefit of himself and his two adult children.